IDXG首席执行官Thomas Burnell表示,随着交易的完成,公司的运营现金流预计每年将增加近500万美元,且将把出售所得用于满足营运资金需求,并用于投资发展分子诊断业务。
$药明康德(SH603259)$ $泰格医药(SZ...查看全文
Interpace(IDXG)2020-04-18 04:45
$Interpace诊断(IDXG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-20-000269 Act: 34 Size: 61 KB 网页链接查看全文
Interpace(IDXG)2020-02-11 05:15
$Interpace诊断(IDXG)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001493152-20-001864 Size: 4 KB 网页链接查看全文
Interpace(IDXG)2020-01-24 06:20
$Interpace诊断(IDXG)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001192482-20-000053 Size: 7 KB 网页链接查看全文
Interpace(IDXG)2020-01-24 06:50
$Interpace诊断(IDXG)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001493152-20-000992 Act: 34 Size: 136 KB 网页链接查看全文
Interpace(IDXG)2020-04-07 05:55
$Interpace诊断(IDXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-20-005921 Size: 4 KB 网页链接查看全文
Interpace(IDXG)2020-01-28 05:40
$Interpace诊断(IDXG)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001493152-20-001162 Act: 33 Size: 16 KB 网页链接查看全文
美股滚雪球2022-09-01 14:10
美国生物医药机构Flagship Biosciences买下了$Interpace(IDXG)$ 旗下的制药业务。
IDXG首席执行官Thomas Burnell表示,随着交易的完成,公司的运营现金流预计每年将增加近500万美元,且将把出售所得用于满足营运资金需求,并用于投资发展分子诊断业务。
$药明康德(SH603259)$ $泰格医药(SZ...查看全文
不乱下2019-04-25 11:27
$Interpace诊断(IDXG)$ 从事于美国甲状腺癌/胰腺癌组织LDT基因诊断服务(不是液体活检),这是一家LDT服务商。 IDXG的主要产品都是并购过来的资产,所以这家公司的定位就是一个商业化公司而不是一个技术公司。 按照公司的说法,公司在甲状腺癌组织基因诊断服务方面技术上还是领先的,而胰腺癌好像...查看全文
$Interpace Diagnostics(IDXG)$ 8-K - Current report Filed: 2016-12-19 AccNo: 0001437749-16-043513 Size: 622 KBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-11-18 AccNo: 0001437749-16-042388 Size: 190 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-11-08 AccNo: 0000892712-16-001992 Size: 55 KB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-11-03 AccNo: 0001437749-16-040997 Size: 173 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrange...
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-10-26 AccNo: 0001437749-16-040346 Size: 101 KB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-10-20 AccNo: 0001437749-16-040018 Size: 125 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersI...
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-10-19 AccNo: 0000892712-16-001941 Size: 55 KB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-10-14 AccNo: 0001437749-16-039845 Size: 150 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersI...
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-10-13 AccNo: 0001437749-16-039798 Size: 26 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-10-04 AccNo: 0001437749-16-039482 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangeme...